Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 15,201–15,220 of 17,987 drug recalls

Drug Recall Terminated Historical recordClass II

LOSARTAN POTASSIUM Tablets, USP, 50 mg, 30 count bottles, Rx only, Manufactured by Arrow Pharm (Malta) Ltd., Bizebbugia, Malta, Packaged by GSMS, Inc. Camarillo, CA --- NDC 60429-317-30

by Golden State Medical Supply Inc.

Reason
Presence of Foreign Substance; some bottles may contain debris that was swept up during cleaning
Recall initiated
April 14, 2014
Reported by FDA
June 11, 2014
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

GREENSTONE BRAND fluconazole for Oral Suspension, ORANGE FLAVORED, 40 mg/mL, when reconstituted, Rx only, Distributed by Greenstone LLC Peapack, NJ 07977. MADE IN INDIA. NDC 59762-5030-1

by Pfizer Inc.

Reason
Defective Container: Tamper evident ring failures discovered on some bottles.
Recall initiated
January 29, 2014
Reported by FDA
June 11, 2014
Distribution
Nationwide, Italy and Republic of South Korea

View recall →

Drug Recall Terminated Historical recordClass II

Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Water view Blvd., Parsippany, NJ 07054, USA. NDC: 64679-736-02.

by Wockhardt Usa Inc.

Reason
Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.
Recall initiated
April 10, 2014
Reported by FDA
June 4, 2014
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

ParaGard T 380A - Intrauterine Copper Contraceptive, 176 mg of copper wire, Duramed Pharmaceuticals Inc, a subsidiary of Barr Pharmaceuticals, Inc., Pomona, NY

by Teva Pharmaceuticals USA

Reason
Non-sterility: due to a failed sterility test
Recall initiated
March 21, 2014
Reported by FDA
June 4, 2014
Distribution
NY and KY

View recall →

Drug Recall Terminated Historical recordClass III

PediaCare brand DAY & NIGHT Value Pack DAYTIME MULTI-SYMPTOM Cold (dextromethorphan HBr 5 mg and Phenylephrine HCl 2.5 mg) and NIGHTTIME MULTI-SYMPTOM Cold (diphenhydramine HCl 6.25 mg and phenylephrine HCl 2.5 mg), 4 FL oz (118 mL) bottles, one each of DAYTIME MULTI-SYMPTOM Cold, Distributed by Medtech Products, Inc., Tarrytown, NY --- UPC 814832013523

by Prestige Brands Holdings

Reason
Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution
Recall initiated
April 25, 2014
Reported by FDA
June 4, 2014
Distribution
Nationwide, and one consignee in Libya

View recall →

Drug Recall Terminated Historical recordClass III

PediaCare brand NIGHTTIME MULTI-SYMPTOM Cold, (diphenhydramine HCl 6.25 mg and phenylephrine HCl 2.5 mg), 4 FL OZ (118 mL), Distributed by Medtech Products, Inc., Tarrytown,NY ---- UPC 814832013544

by Prestige Brands Holdings

Reason
Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution
Recall initiated
April 25, 2014
Reported by FDA
June 4, 2014
Distribution
Nationwide, and one consignee in Libya

View recall →

Drug Recall Terminated Historical recordClass I

Burn 7 Capsules, supplied in 30 capsules bottle

by Deseo Rebajar

Reason
Marketed Without an Approved NDA/ANDA: Undeclared sibutramine and phenolphthalein in Burn 7 dietary supplement
Recall initiated
December 23, 2013
Reported by FDA
June 4, 2014
Distribution
Puerto Rico only

View recall →

Drug Recall Terminated Historical recordClass II

Cefpodoxime Proxetil Tablets, USP, 200 mg, 20 Tablet Bottles, Rx Only. Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540. NDC 0781-5439-20.

by Sandoz, Inc

Reason
Presence of Foreign Substance: Presence of stainless steel particles.
Recall initiated
May 22, 2014
Reported by FDA
June 4, 2014
Distribution
Nationwide including Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Red Yeast Rice High Potency Dietary Supplement, 600 mg, packaged in a) 120-count VegeCaps per bottle (UPC 8 01650 02205 9) and b) 500-count VegeCaps per bottle (UPC 8 01650 02206 6), Manufactured by: Back to Health, Eugene, Oregon 97402.

by Independent Nutrition Center, Inc.

Reason
Marketed Without An Approved NDA/ANDA: Product is being recalled due to excessive levels of lovastatin. Lovastatin is an FDA approved drug making this dietary supplement an unapproved new drug.
Recall initiated
April 29, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pharmaceutica NV, Belgium, Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, NDC 0456-1420-30

by Forest Pharmaceuticals Inc

Reason
Failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.
Recall initiated
May 12, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass III

Oasis TEARS, Lubricant Eye Drops, 10mL/0.3 fl. oz. Bottle, OTC Only. Distributed by: OASIS, OASIS Medical, Inc., Glendora, CA 91741. UPC: 8 54819 00002 3.

by Oasis Medical Inc

Reason
Labeling: Missing Label; The label on the immediate bottle is missing.
Recall initiated
May 14, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide in US

View recall →

Drug Recall Terminated Historical recordClass I

NATURECT Capsules Dietary Supplement 500 mg, supplied in 1 count blister pack and 5, 10, 20, and 40- count bottles, Distributed by P-Boost, Los Angeles, CA 900466

by Tendex

Reason
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to contain undeclared active ingredient, tadalafil, thus making these products unapproved drugs.
Recall initiated
November 19, 2013
Reported by FDA
May 28, 2014
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass I

P-BOOST Capsules Dietary Supplement 500 mg, supplied in 1 count blister pack and 5, 10, 20, and 40- count bottles, Distributed by P-Boost, Los Angeles, CA 900466

by Tendex

Reason
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to contain undeclared active ingredient, tadalafil, thus making these products unapproved drugs.
Recall initiated
November 19, 2013
Reported by FDA
May 28, 2014
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.

by SigmaPharm Laboratories LLC

Reason
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Recall initiated
April 22, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

phosLo (calcium acetate) GelCaps, 667 mg, 200-count bottle, Rx only, Manufactured for Fresenius Medical Care North America, Waltham, MA 02451, NDC 0781-2081-02

by Fresenius Medical Care Holdings, Inc.

Reason
Cross Contamination with Other Products: Potential for contaminant on the cotton packaging inside the bottle. Chemical analysis of the contaminant found on the cotton was identified as a formulation of 4% Trimipramine methanesulfonate - a tricyclic antidepressant..
Recall initiated
April 14, 2014
Reported by FDA
May 28, 2014
Distribution
PA

View recall →

Drug Recall Terminated Historical recordClass II

PROMETHAZINE HYDROCHLORIDE Tablets, USP, 25 mg, 100 Tablet Bottles, Rx Only. Manufactured by: Cadila Healthcared Ltd., India. Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534. NDC: 68382-041-01

by Zydus Pharmaceuticals USA Inc

Reason
Presence of Foreign Tablets: Presence of atenolol 25 mg tablet mixed into promethazine 25 mg tablet bottles.
Recall initiated
May 8, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

QVAR¿ (beclomethasone dipropionate HFA), 80mcg Inhalation Aerosol, 50 metered inhalations/120 metered inhalations, packaged in an aluminum cylinder, Mktd. by: Teva Respiratory, LLC, Horsham, PA, Mfd. by: 3M Drug Delivery Systems, Northridge, CA.

by Teva Pharmaceuticals USA

Reason
Defective Delivery System; defective valve
Recall initiated
April 23, 2014
Reported by FDA
May 28, 2014
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

XZEN PLATINUM, 750 mg, Distributed by: XZEN, Los Angeles, CA.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Recall initiated
January 9, 2014
Reported by FDA
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

View recall →

Drug Recall Terminated Historical recordClass I

ExtenZe 600 mg, 30 tablet box, Manufactured for: Biotab Nutraceuticals, Inc., Pasadena, CA.

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Recall initiated
January 9, 2014
Reported by FDA
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

View recall →

Drug Recall Terminated Historical recordClass I

Magic For Men, packaged in 1ct blister pack and 12-pill/bottle, 390 mg Manufactured For: BTQ Ski, Inc., Chicago, IL 60638

by Schindele Enterprises dba Midwest Wholesale

Reason
Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.
Recall initiated
January 9, 2014
Reported by FDA
May 28, 2014
Distribution
Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.